The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom

The Effect of Bunsimgi-eum(Fenxinqiyin) on the Chest Discomfort of Hwa-byung's Major Symptom : Randomized, Double-blinded, Placebo-control Trial

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01270048

Enrollment

144

Registered

2011-01-05

Start date

2008-05-31

Completion date

2009-08-31

Last updated

2011-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hwa-byung (Disorder)

Keywords

Hwa-byung, Bunsimgi-eum(Fenxinqiyin)

Brief summary

The purpose of this research is to examine the effect of Bunsimgi-eum on the chest discomfort of Hwa-byung's major symptom and develope and establish pattern identification system in Hwa-byung.

Interventions

DRUGmild-ex-gwarip

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

OTHERPlacebo

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to 65 Years

Healthy volunteers

Inclusion criteria

* male or female aged 20-65 * subjects who meet structured interview criteria for Hwa-Byung Diagnosis

Exclusion criteria

* duration of illness less than 6 months * current or past history of delusions, hallucination * past history of at least one manic episode, hypomanic episode, or mixed episode * current or past history of alcohol abuse or alcohol dependence history * taking substances(e.g. steroids) which might affect symptoms * medical conditions(e.g. hyperthyroidism, hypothyroidism, heart disease) that might affect symptoms * current with hepatoma, hepatic cirrhosis, chronic renal failure, congestive heart failure * pregnancy, lactation, women not using medically accepted means of birth control * considered not apt to carry out clinical trial

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026